Skip to content | Change text size
 

David C M Kong

Photo of Dr David Kong, Lecturer

Lecturer (Department of Pharmacy Practice)

GCHE, Monash; BPharm, VCP; MPharm, Monash; PhD, Monash

Contact Information

Phone: + 613 9903 9035
Fax: + 613 99039629
Email: david.kong@pharm.monash.edu.au

Other Appointments

  • Pharmacist (Pharmacy Dept., The Alfred Hospital)
  • Honorary Lecturer (Dept. of Epidemiology and Preventive Medicine, faculty of Medicine, Monash University)

Examples of current committee appointments and academic interests

  • Executive Member, Australian Society of Antimicrobials
  • Chair, Infectious Diseases Committee of Specialty Practice of SHPA
  • Member, The Royal Melbourne Hospital Antimicrobial Subcomittee
  • Board Member, faculty of Information Technology, Monash University
  • Member, The Alfred Ethic’s Research Review Committee, The Alfred
  • Member, Medication Safety COSP, Society of Hospital Pharmacist of Australia
  • Member, Royal Australian Chemical Institute
  • Member, Society of Hospital Pharmacy of Australia

Research Interests

  • Quality use of anti-infectives
  • Pharmacokinetic and Pharmacodynamics of anti-infectives and immunosuppresants
  • Medication safety and adherance

Honours, Masters and PhD projects for 2008

Examples of awards and grants

2005

Identifying the activities and time commitments of clinical pharmacists according to patients' diagnosis related group classification(Bristol Myler Squibb Clinical Pharmacy Research Grant - SHPA - $20,000)
Investigators:  Stuchbery P, De Santis G and Kong DCM
 2003-2005

Monash Research Funds for the Facility for Anti-infective Drug Development and Innovation (Monash University - $450,000)
Investigators:  Nation RL, Rayner CR, Charman S, Kong DCM and Doherty M
 2003-2005 Medication Alert Project (Department of Human Services - ~$1,500,000)
Investigators: Kong DCM, Jones J and the Medication Alert Consortium
2003

Community-acquired pneumonia: Towards improving outcomes nationally (National prescribing Services, $185,000).
Investigators: Kirsa S, Thomson, W, Robertson M, Dartnell J, Korman T, O'reilly M, Kong DCM, Dunkley K and Marriott J representing the Victorian Drug Use Evaluation Group.
 2003 Novartis Hospital Grant for Development of Medication-based risk assessment  tool  (SHPA - $10,000)
Investigators: Kong DCM, George J and Stewart K
 2002 Improving Patient’s Medication (Australian Council for Safety and Quality in Health Care SIIP - $49,625)
Investigators: Kong DCM, Jones J, Hirth K and van De Vreede M
 2002 Novartis Hospital Grant for Triangulation approach towards investigating adherence in patients with COPD (SHPA - $10,000)
Investigators: Kong DCM, George J and Stewart K
 2001 Community Liaison Pharmacist Project Grant (DHS - $79,900)
Investigators: Vuong T, Kong DCM and Marriott J
 2001 Monash University Project Grant for Investigation into the placenta transfer of  protease inhibitors ($30,000)
Investigators: Rayner CR, Kong DCM, Ghabrial H and Angus P

Examples of articles in peer-review journals

  1. Stuchbery P, Kong DCM, deSantis GN and Lo SK.  measuring the time required to provide the components of clinical pharmacy services. J. Pharm. Prac. Res. 37(2): 102-107 (2007). 
  2. Sudhakaran S, Rayner CR, Li J, Kong DCM, Gude NM and Nation RL. Differential Protein Binding of Indinavir and Saquinavir in Matched Maternal and Umbilical Cord Plasma. Brit. J. Clin. Pharm. 63(3): 315-321 (2007) Epub 2006 Sept 19.
  3. Hassali MA, Kong DCM and Stewart K.  A comparison between senior medical students' and pharmacy pre-registrants' knowledge and perceptions of generic medicines, J. Medical Education, 41; 703-710 (2007).
  4. Hassali MA, Kong DCM and Stewart K.  Knowledge and perceptions of recent pharmacy graduates about generic medicines. Pharmacy Education, 7(1): 89-95 (2007).
  5. Geroge J, Kong DCM, Santamaria NM, Ioannides-Demos LL and Stewart K.  Adherence to disease management interventions for chronic obstructive pulmonary disease patients: patient's perspective.  J. Pharm. Pract. Res. 36(4): 279-286 (2006).
  6. Hassali MA, Kong DCM and Stewart K. Generic Medicines: Perceptions of General Practitioners in Melbourne, Australia. J. Generic Medicine. 3(3): 214-225 (2006).
  7. Larizza M, Dooley MJ, Stewart K and Kong DCM. A Pilot Exploration of Factors Influencing Adherence to Molecular Therapies in Haematology-Oncology Out-Patients. J. Pharm. Pract. Res. 36(2): 115-118 (2006).
  8. George J, Kong DCM, Santamaria NM, Ioannides-Demos LL, and Stewart K. Smoking Cessation: COPD Patients’ Perspective. J. Pharm. Pract. Res.  36(2): 107-110 (2006).
  9. George J, Vuong T, Bailey MJ, Kong DCM, Marriott JM and Stewart K. Regimen Complexity and Medication Adherence in Patients at Risk for Medication Misadventure. J. Pharm. Pract. Res. 36(2): 99-102 (2006).
  10. George J, Mackinnon A, Kong DCM and Stewart K. Development and Validation of the Beliefs & Behaviour Questionnaire (BBQ). Patient Education & Counselling.: 64: 50-60(2006).
  11. George J, Vuong T, Bailey M, Kong DCM, Marriott JM and Stewart K. Development and Validation of the Medication-Based Disease Burden Index. Ann. Pharmacotherapy. 40(4): 645-650 (2006).
  12. Hassali MA, Kong DCM and Stewart K. Generic Medicines: Perceptions of Community Pharmacists in Melbourne, Australia. J. Pharma. Finance, Economics and Policy. 14(3): 27-45 (2006).
  13. Hassali MA, Kong DCM and Stewart K, Generic Medicines: Perceptions of Consumers in Melbourne, Australia. Int. J. Pharm. Prac. 13(4): 257-264 (2005).
  14. George J, Kong DCM, Thoman R and Stewart K. Factors Associated with Medication Nonadherence in Patients with COPD. Chest. 128(5): 3198-3204 (2005).
  15. Sudhakaran S, Ghabrial H, Nation R, Kong DCM, Gude NM, Angus PW and Rayner CR. Differential Bidirectional Transfer of Indinavir in the isolated perfused human placental model. Antimicrobial Agents Chemotherapy, 49, 1023-1028 (2005).
  16. Levy RW, Rayner CR, Fairly K, Kong DCM, Mijch A, Costello K, McArthur C and the Melbourne Adherence Group. Multi-disciplined HIV Adherence Intervention – A Randomised Study. Aids Patient Care And STDS, 18(12), 728-735 (2004).
  17. Hassali A, Kong DCM and Stewart K. Utilization of generic medicines in the Australian Health Care System, J. Generic Medicine, 2(1): 201-206 (2004).
  18. George J, Ioannides-Demos LL, Santamaria N, Kong DCM and Stewart K. Use of complementary and alternative medicines use by patients with chronic obstructive pulmonary disease – Med J. Australia, 181: 248-251 (2004).
  19. Yuriev E, Kong DCM and Iskander MN. Investigation of Structure-Activity Relationships in a Series of Glibenclamide Analogues. Eur. J. Med.Chem., 39: 835-847 (2004).
  20. George J, Phun Y-T, Bailey M, Kong DCM and Stewart K. Development and validation of Medication Regimen Complexity Index: . Ann. Pharmcotherapy; 38: 1369-1376 (2004).
  21. Fairley CK, Levy R, Rayner CR, Allardice K, Costello K, Thomas C, McArthur C, Kong D, Mijch A and the Melbourne Adherance Group. Randomised trial of an adherence program for clients with HIV, Int. J. STD and AIDS, 14: 805-809 (2003).
  22. Snell G, Kotsimbos TC, Levvey, B, Skiba M, Rutherford DM, Kong DCM, Williams TJ and Krum H. Pharmacokinetics Assessment of Oral Ganciclovir in Lung Transplant Recipients with Cystic Fibrosis, J. Antimicrob. Chemothera., 45: 511-516 (2000).
  23. Kong DCM and von Iztstein M. The chemoenzymatic synthesis of 9-substituted-3,9-dideoxy-D-glycero-D-galacto-2-nonulosonic acids, Carbohydr. Res., 305: 323-329 (1998).   
  24. Terada T, Kitajima K, Inoue S, Wilson JC, Norton AK, Kong DCM, Thomson RJ, von Itzstein M and Inoue Y. Catalysis by a new sialidase, deaminoneuraminic acid residue-cleaving enzyme (KDNase Sm), initially forms a less stable a-anomer of 3-deoxy-D-glycero-D-galacto-nonulosonic acid and is strongly inhibited by the transition state analog, 2-deoxy-2,3-didehydro-D-glycero-D-galacto-2-nonulopyranosonic acid, but not by 2-deoxy-2,3-didehydro-N-acetylneuraminic  acid, J. Biol. Chem., 272: 5452-5456 (1997).
  25. McPherson GA, Choi RT, Kong DCM and Iskander MN. The thromboxane-A2 and KATP channel antagonist actions of a series of sulphonylurea  derivatives in the pig coronary artery, Eur. J. Pharmacol., 324: 193-200 (1997).
  26. Wu W-Y, Jin B, Kong DCM and von Itzstein M. A facile synthesis of a useful 5-N-substituted-3,5-dideoxy-D-glycero-D-galacto-2-nonulosonic acid from 2-acetamino-2-deoxy-D-glucose, Carbohydr. Res., 300: 171-174 (1997).
  27. Wilson JC, Kong DCM, Li Y-T and von Itzstein M. A 1H NMR investigation of the hydrolysis of a synthetic substrate by KDN-Sialidase from Crassostrea virginica, Glycoconj. J., 13: 927-931 (1996).
  28. Kong DCM and von Itzstein, M. The first synthesis of a C-7 Nitrogen-containing sialic acid analogue, 5-acetamido-7-azido-3,5,7-trideoxy-D-glycero-D-galacto-2-nonulopyrasonic acid (7-azido-7-deoxy-Neu5Ac), Tet. Lett., 36 (6), 957-960 (1995).
  29. Challinor-Rogers JL, Kong DCM, Iskander MN. and McPherson GA. Structure-Activity Relationship of Glibenclamide analogs: A comparison of potency as Levcromakalim antagonists in rat aorta vs affinity for [3H]-Glibenclamide binding to membranes from rat cerebral cortex, J. Pharmacol. Exp. Ther., 273, 778-786 (1995).